Sunitinib for Asian Patients with Advanced Renal Cell Carcinoma: A Comparable Efficacy with Different Toxicity Profiles

Oncology ◽

10.1159/000330361 ◽

2011 ◽

Vol 80 (5-6) ◽

pp. 395-405 ◽

Author(s):

Hyo Song Kim ◽

Min Hee Hong ◽

Kiyeol Kim ◽

Sang-Joon Shin ◽

Joong-Bae Ahn ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Advanced Renal Cell Carcinoma ◽

Comparable Efficacy ◽

Download Full-text

Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical Setting

Translational Oncology ◽

10.1016/j.tranon.2020.100771 ◽

2020 ◽

Vol 13 (6) ◽

pp. 100771

Author(s):

Renpei Kato ◽

Daiki Ikarashi ◽

Tomohiko Matsuura ◽

Shigekatsu Maekawa ◽

Yoichiro Kato ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Clinical Setting ◽

Advanced Renal Cell Carcinoma ◽

Clinical Safety ◽

The Real ◽

Download Full-text

Phase II Study of the Safety and Efficacy of Temsirolimus in East Asian Patients with Advanced Renal Cell Carcinoma†

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hys110 ◽

2012 ◽

Vol 42 (9) ◽

pp. 836-844 ◽

Author(s):

Yan Sun ◽

Sun Rha ◽

Se-Hoon Lee ◽

Jun Guo ◽

Takeshi Ueda ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Renal Cell Carcinoma ◽

Safety And Efficacy ◽

Asian Patients ◽

East Asian Patients

Download Full-text

Sunitinib for unselected Korean patients with advanced renal cell carcinoma: A comparable efficacy with different toxicity profiles.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e15107 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e15107-e15107 ◽

Author(s):

H. Kim ◽

M. Hong ◽

S. J. Shin ◽

J. Ahn ◽

H. C. Chung ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Advanced Renal Cell Carcinoma ◽

Comparable Efficacy ◽

Korean Patients

Download Full-text

1305: Zoledronic Acid Reduces Long-Term Risk of Skeletal Complications in Patients with Advanced Renal Cell Carcinoma or Bladder Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)31519-2 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 429-430 ◽

Author(s):

Peter F. Mulders ◽

Kurt Miller ◽

N. Simon Tchekmedyian

Keyword(s):

Renal Cell Carcinoma ◽

Bladder Cancer ◽

Zoledronic Acid ◽

Cell Carcinoma ◽

Advanced Renal Cell Carcinoma ◽

Skeletal Complications

Download Full-text

Sunitinib Superior to Interferon-α For Advanced Renal Cell Carcinoma

Internal Medicine News ◽

10.1016/s1097-8690(06)74366-9 ◽

2006 ◽

Vol 39 (20) ◽

pp. 35

Author(s):

FRAN LOWRY

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Advanced Renal Cell Carcinoma ◽

Download Full-text

FDA approves pembrolizumab plus axitinib for advanced renal cell carcinoma

Case Medical Research ◽

10.31525/fda1-ucm636395.htm ◽

2019 ◽

Author(s):

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Advanced Renal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1119981.576105 ◽

2008 ◽

Author(s):

Sharokh Shariat ◽

Jose Karam

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Interferon Alfa ◽

Advanced Renal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1147883.604974 ◽

2009 ◽

Author(s):

Keith Flaherty ◽

Stephen Keefe

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Primary Tumor ◽

Advanced Renal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13484037.14861147 ◽

2012 ◽

Author(s):

Thomas Powles

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Comparative Effectiveness ◽

Advanced Renal Cell Carcinoma ◽

Download Full-text

Faculty Opinions recommendation of Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737144184.793569177 ◽

2020 ◽

Author(s):

Maria-José Molina-Garrido

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Iii ◽

Advanced Renal Cell Carcinoma

Download Full-text